Spyre Therapeutics Inc.

NASDAQ: SYRE · Real-Time Price · USD
16.93
0.07 (0.42%)
At close: Aug 15, 2025, 3:59 PM
16.95
0.12%
After-hours: Aug 15, 2025, 04:54 PM EDT

Spyre Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
89.42M 188.89M 34.86M 15.14M
Short-Term Investments
513.66M 150.38M 20.85M 77.99M
Long-Term Investments
n/a n/a 1.55M 1.84M
Other Long-Term Assets
10K 331K 683K 842K
Receivables
n/a n/a 375K 815K
Inventory
n/a n/a n/a n/a
Other Current Assets
5.39M 2.25M 6.17M n/a
Total Current Assets
608.47M 341.53M 62.26M 98.89M
Property-Plant & Equipment
n/a n/a 6.65M 8.36M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
10K 331K 8.89M 11.04M
Total Assets
608.48M 341.86M 71.14M 109.93M
Account Payables
666K 896K 677K 3.32M
Deferred Revenue
n/a n/a 517K 2.36M
Short-Term Debt
n/a n/a n/a n/a
Other Current Liabilities
52.79M 27.03M 4.92M 4.99M
Total Current Liabilities
54.06M 31.98M 14.66M 20.14M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
36.62M 125.86M n/a n/a
Total Long-Term Liabilities
36.62M 125.86M 6.18M 5.84M
Total Liabilities
90.68M 157.84M 20.84M 25.98M
Total Debt
n/a 84.56M 4.63M 5.06M
Common Stock
13K 10K 6K 5K
Retained Earnings
-972.43M -764.41M -425.62M -341.81M
Comprehensive Income
180K 302K -48K -20K
Shareholders Equity
517.8M 184.02M 50.3M 83.94M
Total Investments
513.66M 150.38M 20.85M 77.99M